SNAP Platform Vaccines
Infectious Disease (e.g., SFTS, Avian Influenza)
Pre-clinicalActive
Key Facts
Indication
Infectious Disease (e.g., SFTS, Avian Influenza)
Phase
Pre-clinical
Status
Active
Company
About POP Biotechnologies
POP Biotechnologies leverages its proprietary porphyrin-phospholipid (PoP) nanotechnology to create two primary platform solutions: the SNAP vaccine platform and Chemophototherapy for targeted oncology. The company is advancing a pipeline targeting infectious diseases, cancer, and chronic conditions like Alzheimer's, supported by significant non-dilutive funding from entities like the NIH and CEPI. As a private, platform-focused biotech, POP BIO partners with global health organizations and seeks collaborators to expand the application of its versatile nanoparticle technology.
View full company profile